VitaNova Life Sciences annual shareholders’ equity
2018
2019
2020
2021
2022
2023
2024
2025
2026
VitaNova Life Sciences Shareholders’ Equity Growth & History (VNOV)
VitaNova Life Sciences's shareholders’ equity was $2.1M for fiscal 2026.
View full VitaNova Life Sciences company overviewVitaNova Life Sciences annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-30 | $2.1M | $142,096 | +7.44% |
| 2025 | 2025-04-30 | $1.9M | $852,746 | +80.76% |
| 2024 | 2024-04-30 | $1.1M | $1.1M | — |
| 2023 | 2023-04-30 | −$59,215 | −$24,227 | — |
| 2022 | 2022-04-30 | −$34,988 | $139,682 | — |
| 2021 | 2021-04-30 | −$174,670 | −$52,094 | — |
| 2020 | 2020-04-30 | −$122,576 | −$72,334 | — |
| 2019 | 2019-04-30 | −$50,242 | −$92,397 | — |
| 2018 | 2018-04-30 | $42,155 | — | — |
VitaNova Life Sciences quarterly shareholders’ equity
Q1.18
Q3.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-04-30 | $2.1M | $142,096 | +7.44% |
| Q3 2026 | 2026-01-31 | $1.9M | $745,479 | +67.26% |
| Q2 2026 | 2025-10-31 | $1.9M | $863,319 | +83.42% |
| Q1 2026 | 2025-07-31 | $1.9M | $860,906 | +85.96% |
| Q4 2025 | 2025-04-30 | $1.9M | $852,746 | +80.76% |
| Q3 2025 | 2025-01-31 | $1.1M | $237,570 | +27.28% |
| Q2 2025 | 2024-10-31 | $1.0M | $1.1M | — |
| Q1 2025 | 2024-07-31 | $1.0M | $1.1M | — |
| Q4 2024 | 2024-04-30 | $1.1M | $1.1M | — |
| Q3 2024 | 2024-01-31 | $870,782 | $925,612 | — |
| Q2 2024 | 2023-10-31 | −$92,217 | −$61,964 | — |
| Q1 2024 | 2023-07-31 | −$83,462 | −$50,608 | — |
| Q4 2023 | 2023-04-30 | −$59,215 | −$24,227 | — |
| Q3 2023 | 2023-01-31 | −$54,830 | −$46,649 | — |
| Q2 2023 | 2022-10-31 | −$30,253 | −$13,155 | — |
| Q1 2023 | 2022-07-31 | −$32,854 | −$747 | — |
| Q4 2022 | 2022-04-30 | −$34,988 | $139,682 | — |
| Q3 2022 | 2022-01-31 | −$8,181 | $140,926 | — |
| Q2 2022 | 2021-10-31 | −$17,098 | $129,110 | — |
| Q1 2022 | 2021-07-31 | −$32,107 | $101,716 | — |
| Q4 2021 | 2021-04-30 | −$174,670 | −$52,094 | — |
| Q3 2021 | 2021-01-31 | −$149,107 | −$56,868 | — |
| Q2 2021 | 2020-10-31 | −$146,208 | −$56,563 | — |
| Q1 2021 | 2020-07-31 | −$133,823 | −$63,697 | — |
| Q4 2020 | 2020-04-30 | −$122,576 | −$72,334 | — |
| Q3 2020 | 2020-01-31 | −$92,239 | −$55,593 | — |
| Q2 2020 | 2019-10-31 | −$89,645 | −$89,695 | — |
| Q1 2020 | 2019-07-31 | −$70,126 | −$96,455 | — |
| Q4 2019 | 2019-04-30 | −$50,242 | −$92,397 | — |
| Q3 2019 | 2019-01-31 | −$36,646 | −$82,996 | — |
| Q2 2019 | 2018-10-31 | $50 | −$59,050 | −99.92% |
| Q1 2019 | 2018-07-31 | $26,329 | — | — |
| Q4 2018 | 2018-04-30 | $42,155 | $45,830 | — |
| Q3 2018 · Jan 31 | 2018-01-31 | $46,350 | — | — |
| Q3 2018 · Oct 31 | 2017-10-31 | $59,100 | — | — |
| Q1 2018 | 2017-04-30 | −$3,675 | — | — |
VitaNova Life Sciences shareholders’ equity trends
Over the last five fiscal years, VitaNova Life Sciences's shareholders’ equity increased from −$174,670 to $2.1M, a change of $2.2M. The latest reported quarter, Q4 2026, shows $2.1M.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review VitaNova Life Sciences source filings ↗